Inclusion Criteria:  Participants with MM. Participants who are prescribed and initiate ixazomib for the treatment of MM according to the ixazomib citrate South Korean product label.  Exclusion Criteria:  Participants treated with ixazomib citrate outside of the locally approved label in South Korea. Participants for which ixazomib citrate is contraindicated as per product label.